- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Annual influenza vaccination |
|---|
| Prophylaxis for influenza (in an officially declared non-medical healthcare situation) |
|---|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Children 6 to 36 months of age:
Very common (> 10%): pain, tenderness, erythema at injection site. Headache. Vomiting, diarrhea. Myalgia. Irritability, irritability, loss of appetite, abnormal crying, malaise, fever, drowsiness.
Common (1-10%): induration, swelling, ecchymosis of the injection site. Chills.
Uncommon (0.1-1%): hypersensitivity.
Rare (< 0.1%): Local: rash, itching at the injection site. Systemic allergic reactions such as itching, papular rash.
Also reported: anaphylactic reaction.
Children aged 3 to 18 years:
Very common (> 10%): pain, redness, swelling, hardening at the injection site. Headache, drowsiness. Loss of appetite. Abdominal pain, nausea. Irritability, irritability. Myalgia. Fatigue, malaise.
Common (1-10%): ecchymosis at injection site. Sweating. Diarrhea, vomiting. Arthralgia. Fever, chills.
Uncommon (0.1-1%): heat, itching at injection site. Thrombocytopenia. Restlessness. Dizziness. Abdominal pain.
Furthermore, allergic reactions (in rare cases leading to shock) have been reported. Transient lymphadenopathy. Neuralgia, paresthesia, febrile convulsions, other neurological disorders such as encephalomyelitis, neuritis and Guillain-Barré syndrome. Vasculitis (such as Henoch-Schönlein purpura) with transient kidney problems in very rare cases. Itching, rash.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Encephalitis vaccines | ||
|---|---|---|
| J07BA02 | ||
| J07BA01 | ||
| Hepatitis vaccines | ||
|---|---|---|
| J07BC20 | ||
| J07BC02 | ||
| J07BC01 | ||
| Measles vaccines | ||
|---|---|---|
| J07BD52 | ||
| Poliomyelitis vaccines | ||
|---|---|---|
| J07BF03 | ||
| Rabies vaccines | ||
|---|---|---|
| J07BG01 | ||
| Rota virus diarrhea vaccines | ||
|---|---|---|
| J07BH01 | ||
| Varicella zoster vaccines | ||
|---|---|---|
| J07BK01 | ||
| Yellow fever vaccines | ||
|---|---|---|
| J07BL01 | ||
| Papillomavirus vaccines | ||
|---|---|---|
| J07BM03 | ||
| J07BM02 | ||
| Other viral vaccines | ||
|---|---|---|
| J07BX04 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Solvay Biologicals BV, SPC Influvac (RVG 22289), www.cbg-meb.nl, Geraadpleegd 12 aug 2010, http://db.cbg-meb.nl/IB-teksten/h22289.pdf
- Gezondheidsraad. . 2009;3-5: (geraadpleegd 11 nov 2009), Vaccinatie tegen pandemische influenza A/H1N1 2009: doelgroepen en prioritering (3), www.gezondheidsraad.nl, 2009, 3-5, (geraadpleegd 11 nov 2009)
- GlaxoSmithKline Biologicals BV. , SPC Pandemrix, (EU/1/08/452/001), Geraadpleegd 24-08-2015
- LAREB, Kwartaalbericht 1, 2014
- Novartis Vaccines and Diagnostics. , SPC Focetria, EU/1/07/385/001-002, Geraadpleegd 11 nov 2009
- Vrieze HA et al, NHG/SNPG Handleiding Griepvaccinatie herziening 2016, https://www.nhg.org/sites/default/files/content/nhg_org/uploads/final_nhg_snpg_praktijkhandleiding_griepvaccinatie_2019.pdf
- Abbott Biologicals B.V. , SmPC Influvac Tetra (RVG 119816) 07-08-2019, www.geneesmiddeleninformatiebank.nl
- Sanofi Pasteur Europe, SmPC Vaxigrip Tetra (RVG 117963) 31-07-2019, www.geneesmiddeleninformatiebank.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
